Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 Trial 在既往使用胰岛素治疗血糖未得到控制的日本2型糖尿病受试者中比较德谷胰岛素/门冬胰岛素与每日2次双相门冬胰岛素30:泛亚达标治疗3期试验亚组分析

Saved in:
Bibliographic Details
Title: Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 Trial 在既往使用胰岛素治疗血糖未得到控制的日本2型糖尿病受试者中比较德谷胰岛素/门冬胰岛素与每日2次双相门冬胰岛素30:泛亚达标治疗3期试验亚组分析
Authors: Taneda, Shinji1 taneda@manda.or.jp, Hyllested‐Winge, Jacob2, Gall, Mari‐Anne3, Kaneko, Shizuka4, Hirao, Koichi5
Source: Journal of Diabetes. Mar2017, Vol. 9 Issue 3, p243-247. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17530393
DOI:10.1111/1753-0407.12407